IceCure's ProSense cryoablation system is used to treat patients with T1 invasive breast cancer or those not suited for surgical alternatives.

Over the past 9 years, we've published close to 10,000 articles on Israeli startups, scientific discoveries, and more. These were the most widely read.

Initial results of a clinical trial with 146 patients in 18 hospitals show a promising success rate of up to 99 percent, the biomedical company says.

In honor of Israel's 68th Independence Day, NoCamels highlights Israeli innovations that are changing our lives for the better.

In the future, flying ambulances will carry patients, while people in maglev sky-trains look from the sky-train's windows that can be turned into screens, all while their phones are charged using infrared light. Sounds like a sci-fi movie? Well, it's already being turned into reality in Israel.

Two weeks ago, we published an article about Israel's IceCure, known for its treatment that freezes breast tumors into balls of ice, and which had just announced it would turn its sight on lung cancer. Now we can announce the clinical trial on IceCure’s effectiveness with lung cancer has been successful.

IceCure's amazing tumor-freezing technology destroys breast tumors by freezing them into ice balls. Now, the company is targeting the number one killer-cancer in the US – lung cancer.

There are many methods of treating tumors in the human body, most of which require an invasive procedure which involves general anesthesia. Israeli company IceCure has developed a method that turns tumors into balls of ice – eliminating the need for surgery.

Minimally invasive device IceSense3 uses extremely cold temperatures to destroy fibroadenomas, common benign breast tumors. The Israeli invention now holds promise as a potential treatment for malignant breast tumors, after a successful clinical trial in Japan.